A detailed history of Harbor Capital Advisors, Inc. transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 1,112,592 shares of CDMO stock, worth $13.7 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
1,112,592
Previous 410,039 171.34%
Holding current value
$13.7 Million
Previous $2.93 Million 332.41%
% of portfolio
0.55%
Previous 0.22%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$6.7 - $12.45 $4.71 Million - $8.75 Million
702,553 Added 171.34%
1,112,592 $12.7 Million
Q2 2024

Jul 09, 2024

BUY
$6.34 - $9.28 $1.97 Million - $2.89 Million
310,921 Added 313.69%
410,039 $2.93 Million
Q1 2024

May 13, 2024

BUY
$5.86 - $8.79 $580,831 - $871,247
99,118 New
99,118 $664,000

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $765M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Harbor Capital Advisors, Inc. Portfolio

Follow Harbor Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbor Capital Advisors, Inc. with notifications on news.